Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 511

1.

Test-retest reliability of time-frequency measures of auditory steady-state responses in patients with schizophrenia and healthy controls.

Roach BJ, D'Souza DC, Ford JM, Mathalon DH.

Neuroimage Clin. 2019 Jun 5;23:101878. doi: 10.1016/j.nicl.2019.101878. [Epub ahead of print]

2.

Are Neuroanatomical Abnormalities Underlying Hallucinations Modality-specific?

Ford JM, Hamilton HK.

EClinicalMedicine. 2019 Feb 2;8:8-9. doi: 10.1016/j.eclinm.2019.01.013. eCollection 2019 Feb. No abstract available.

3.

Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations.

Lal A, Ramazzotti D, Weng Z, Liu K, Ford JM, Sidow A.

BMC Med Genomics. 2019 Jun 10;12(1):84. doi: 10.1186/s12920-019-0545-0.

4.

High-Resolution Bisulfite-Sequencing of Peripheral Blood DNA Methylation in Early-Onset and Familial Risk Breast Cancer Patients.

Chen J, Haanpää MK, Gruber JJ, Jäger N, Ford JM, Snyder MP.

Clin Cancer Res. 2019 Jun 7. pii: clincanres.2423.2018. doi: 10.1158/1078-0432.CCR-18-2423. [Epub ahead of print]

PMID:
31175093
5.

Dentate gyrus volume deficit in schizophrenia.

Nakahara S, Turner JA, Calhoun VD, Lim KO, Mueller B, Bustillo JR, O'Leary DS, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Macciardi F, Matsumoto M, Potkin SG, van Erp TGM.

Psychol Med. 2019 Jun 3:1-11. doi: 10.1017/S0033291719001144. [Epub ahead of print]

PMID:
31155012
6.

Adding Depth to Cephalometric Analysis: Comparing Two- and Three-Dimensional Angular Cephalometric Measurements.

Jodeh DS, Kuykendall LV, Ford JM, Ruso S, Decker SJ, Rottgers SA.

J Craniofac Surg. 2019 May 21. doi: 10.1097/SCS.0000000000005555. [Epub ahead of print]

PMID:
31135657
7.

Parallel group ICA+ICA: Joint estimation of linked functional network variability and structural covariation with application to schizophrenia.

Qi S, Sui J, Chen J, Liu J, Jiang R, Silva R, Iraji A, Damaraju E, Salman M, Lin D, Fu Z, Zhi D, Turner JA, Bustillo J, Ford JM, Mathalon DH, Voyvodic J, McEwen S, Preda A, Belger A, Potkin SG, Mueller BA, Adali T, Calhoun VD.

Hum Brain Mapp. 2019 May 16. doi: 10.1002/hbm.24632. [Epub ahead of print]

PMID:
31099151
8.

N-BiC: A method for multi-component and symptom biclustering of structural MRI data: Application to schizophrenia.

Rahaman MA, Turner JA, Gupta CN, Rachakonda S, Chen J, Liu JY, van Erp TGM, Potkin S, Ford JM, Mathalon DH, Lee HJ, Jiang W, Mueller B, Andreassen O, Agartz I, Sponheim SR, Mayer A, Stephen JM, Jung R, Canive J, Bustillo J, Calhoun VD.

IEEE Trans Biomed Eng. 2019 Apr 1. doi: 10.1109/TBME.2019.2908815. [Epub ahead of print]

PMID:
30946659
9.

Group ICA for identifying biomarkers in schizophrenia: 'Adaptive' networks via spatially constrained ICA show more sensitivity to group differences than spatio-temporal regression.

Salman MS, Du Y, Lin D, Fu Z, Fedorov A, Damaraju E, Sui J, Chen J, Mayer AR, Posse S, Mathalon DH, Ford JM, Van Erp T, Calhoun VD.

Neuroimage Clin. 2019;22:101747. doi: 10.1016/j.nicl.2019.101747. Epub 2019 Mar 5.

10.

A method for building a genome-connectome bipartite graph model.

Yu Q, Chen J, Du Y, Sui J, Damaraju E, Turner JA, van Erp TGM, Macciardi F, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Preda A, Vaidya J, Pearlson GD, Calhoun VD.

J Neurosci Methods. 2019 May 15;320:64-71. doi: 10.1016/j.jneumeth.2019.03.011. Epub 2019 Mar 19.

PMID:
30902651
11.

Relevance of experimental paradigms of anesthesia induced neurotoxicity in the mouse.

Johnson SC, Pan A, Sun GX, Freed A, Stokes JC, Bornstein R, Witkowski M, Li L, Ford JM, Howard CRA, Sedensky MM, Morgan PG.

PLoS One. 2019 Mar 21;14(3):e0213543. doi: 10.1371/journal.pone.0213543. eCollection 2019.

12.

The spatial chronnectome reveals a dynamic interplay between functional segregation and integration.

Iraji A, Deramus TP, Lewis N, Yaesoubi M, Stephen JM, Erhardt E, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD.

Hum Brain Mapp. 2019 Jul;40(10):3058-3077. doi: 10.1002/hbm.24580. Epub 2019 Mar 18.

PMID:
30884018
13.

Positive and general psychopathology associated with specific gray matter reductions in inferior temporal regions in patients with schizophrenia.

Mennigen E, Jiang W, Calhoun VD, van Erp TGM, Agartz I, Ford JM, Mueller BA, Liu J, Turner JA.

Schizophr Res. 2019 Jun;208:242-249. doi: 10.1016/j.schres.2019.02.010. Epub 2019 Feb 26.

PMID:
30819594
14.

Auditory and Visual Oddball Stimulus Processing Deficits in Schizophrenia and the Psychosis Risk Syndrome: Forecasting Psychosis Risk With P300.

Hamilton HK, Woods SW, Roach BJ, Llerena K, McGlashan TH, Srihari VH, Ford JM, Mathalon DH.

Schizophr Bull. 2018 Dec 8. doi: 10.1093/schbul/sby167. [Epub ahead of print]

PMID:
30753731
15.

3D analysis of computed tomography (CT)-derived lumbar spine models for the estimation of sex.

Decker SJ, Foley R, Hazelton JM, Ford JM.

Int J Legal Med. 2019 Jan 31. doi: 10.1007/s00414-019-02001-8. [Epub ahead of print]

PMID:
30706193
16.

Efference copy/corollary discharge function and targeted cognitive training in patients with schizophrenia.

Roach BJ, Ford JM, Biagianti B, Hamilton HK, Ramsay IS, Fisher M, Loewy R, Vinogradov S, Mathalon DH.

Int J Psychophysiol. 2018 Dec 29. pii: S0167-8760(18)31017-1. doi: 10.1016/j.ijpsycho.2018.12.015. [Epub ahead of print]

PMID:
30599145
17.

Spatial dynamics within and between brain functional domains: A hierarchical approach to study time-varying brain function.

Iraji A, Fu Z, Damaraju E, DeRamus TP, Lewis N, Bustillo JR, Lenroot RK, Belger A, Ford JM, McEwen S, Mathalon DH, Mueller BA, Pearlson GD, Potkin SG, Preda A, Turner JA, Vaidya JG, van Erp TGM, Calhoun VD.

Hum Brain Mapp. 2019 Apr 15;40(6):1969-1986. doi: 10.1002/hbm.24505. Epub 2018 Dec 26.

PMID:
30588687
18.

Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Clark VP, Mueller BA, de Zwarte SMC, Ophoff RA, van Haren NEM, Andreassen OA, Gurholt TP, Gruber O, Kraemer B, Richter A, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Catts S, Fullerton JM, Green MJ, Henskens F, Jablensky A, Mowry BJ, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Hong E, Kochunov P, Gur RE, Gur RC, Ford JM, Macciardi F, Mathalon DH, Potkin SG, Preda A, Fan F, Ehrlich S, King MD, De Haan L, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, Pomarol-Clotet E, Kelly S, Ciufolini S, Radua J, Murray R, Marques TR, Simmons A, Borgwardt S, Schönborn-Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Yun JY, Cannon DM, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, McIntosh AM, Whalley HC, Knöchel C, Oertel-Knöchel V, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2019 Apr 1;85(7):e35-e39. doi: 10.1016/j.biopsych.2018.10.003. Epub 2018 Nov 22. No abstract available.

PMID:
30470561
19.

Forensic personal identification utilizing part-to-part comparison of CT-derived 3D lumbar models.

Decker SJ, Ford JM.

Forensic Sci Int. 2019 Jan;294:21-26. doi: 10.1016/j.forsciint.2018.10.018. Epub 2018 Oct 29.

PMID:
30445251
20.

Effects of conflict and strategic processing on neural responses to errors in schizophrenia.

Donaldson KR, Roach BJ, Ford JM, Lai K, Sreenivasan KK, Mathalon DH.

Biol Psychol. 2019 Jan;140:9-18. doi: 10.1016/j.biopsycho.2018.11.001. Epub 2018 Nov 11.

PMID:
30428312
21.

Gamma Band Phase Delay in Schizophrenia.

Roach BJ, Ford JM, Mathalon DH.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Feb;4(2):131-139. doi: 10.1016/j.bpsc.2018.08.011. Epub 2018 Aug 31.

PMID:
30314905
22.

A framework for linking resting-state chronnectome/genome features in schizophrenia: A pilot study.

Rashid B, Chen J, Rashid I, Damaraju E, Liu J, Miller R, Agcaoglu O, van Erp TGM, Lim KO, Turner JA, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen S, Potkin SG, Preda A, Bustillo JR, Pearlson GD, Calhoun VD.

Neuroimage. 2019 Jan 1;184:843-854. doi: 10.1016/j.neuroimage.2018.10.004. Epub 2018 Oct 6.

PMID:
30300752
23.

Deficient auditory predictive coding during vocalization in the psychosis risk syndrome and in early illness schizophrenia: the final expanded sample.

Mathalon DH, Roach BJ, Ferri JM, Loewy RL, Stuart BK, Perez VB, Trujillo TH, Ford JM.

Psychol Med. 2018 Sep 25:1-8. doi: 10.1017/S0033291718002659. [Epub ahead of print]

PMID:
30249315
24.

From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.

Trosman JR, Weldon CB, Gradishar WJ, Benson AB 3rd, Cristofanilli M, Kurian AW, Ford JM, Balch A, Watkins J, Phillips KA.

Value Health. 2018 Sep;21(9):1062-1068. doi: 10.1016/j.jval.2018.06.011. Epub 2018 Aug 3.

25.

Salience-Default Mode Functional Network Connectivity Linked to Positive and Negative Symptoms of Schizophrenia.

Hare SM, Ford JM, Mathalon DH, Damaraju E, Bustillo J, Belger A, Lee HJ, Mueller BA, Lim KO, Brown GG, Preda A, van Erp TGM, Potkin SG, Calhoun VD, Turner JA.

Schizophr Bull. 2019 Jun 18;45(4):892-901. doi: 10.1093/schbul/sby112.

PMID:
30169884
26.

NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018.

Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ, Chung DC, Mayer RJ, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2018 Aug;16(8):939-949. doi: 10.6004/jnccn.2018.0067.

PMID:
30099370
27.

Surgical and molecular characterization of primary and metastatic disease in a neuroendocrine tumor arising in a tailgut cyst.

Erdrich J, Schaberg KB, Khodadoust MS, Zhou L, Shelton AA, Visser BC, Ford JM, Alizadeh AA, Quake SR, Kunz PL, Beausang JF.

Cold Spring Harb Mol Case Stud. 2018 Oct 1;4(5). pii: a003004. doi: 10.1101/mcs.a003004. Print 2018 Oct.

28.

Multimodal neuromarkers in schizophrenia via cognition-guided MRI fusion.

Sui J, Qi S, van Erp TGM, Bustillo J, Jiang R, Lin D, Turner JA, Damaraju E, Mayer AR, Cui Y, Fu Z, Du Y, Chen J, Potkin SG, Preda A, Mathalon DH, Ford JM, Voyvodic J, Mueller BA, Belger A, McEwen SC, O'Leary DS, McMahon A, Jiang T, Calhoun VD.

Nat Commun. 2018 Aug 2;9(1):3028. doi: 10.1038/s41467-018-05432-w.

29.

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, Pearlson GD, Yao N, Fukunaga M, Hashimoto R, Okada N, Yamamori H, Bustillo JR, Clark VP, Agartz I, Mueller BA, Cahn W, de Zwarte SMC, Hulshoff Pol HE, Kahn RS, Ophoff RA, van Haren NEM, Andreassen OA, Dale AM, Doan NT, Gurholt TP, Hartberg CB, Haukvik UK, Jørgensen KN, Lagerberg TV, Melle I, Westlye LT, Gruber O, Kraemer B, Richter A, Zilles D, Calhoun VD, Crespo-Facorro B, Roiz-Santiañez R, Tordesillas-Gutiérrez D, Loughland C, Carr VJ, Catts S, Cropley VL, Fullerton JM, Green MJ, Henskens FA, Jablensky A, Lenroot RK, Mowry BJ, Michie PT, Pantelis C, Quidé Y, Schall U, Scott RJ, Cairns MJ, Seal M, Tooney PA, Rasser PE, Cooper G, Shannon Weickert C, Weickert TW, Morris DW, Hong E, Kochunov P, Beard LM, Gur RE, Gur RC, Satterthwaite TD, Wolf DH, Belger A, Brown GG, Ford JM, Macciardi F, Mathalon DH, O'Leary DS, Potkin SG, Preda A, Voyvodic J, Lim KO, McEwen S, Yang F, Tan Y, Tan S, Wang Z, Fan F, Chen J, Xiang H, Tang S, Guo H, Wan P, Wei D, Bockholt HJ, Ehrlich S, Wolthusen RPF, King MD, Shoemaker JM, Sponheim SR, De Haan L, Koenders L, Machielsen MW, van Amelsvoort T, Veltman DJ, Assogna F, Banaj N, de Rossi P, Iorio M, Piras F, Spalletta G, McKenna PJ, Pomarol-Clotet E, Salvador R, Corvin A, Donohoe G, Kelly S, Whelan CD, Dickie EW, Rotenberg D, Voineskos AN, Ciufolini S, Radua J, Dazzan P, Murray R, Reis Marques T, Simmons A, Borgwardt S, Egloff L, Harrisberger F, Riecher-Rössler A, Smieskova R, Alpert KI, Wang L, Jönsson EG, Koops S, Sommer IEC, Bertolino A, Bonvino A, Di Giorgio A, Neilson E, Mayer AR, Stephen JM, Kwon JS, Yun JY, Cannon DM, McDonald C, Lebedeva I, Tomyshev AS, Akhadov T, Kaleda V, Fatouros-Bergman H, Flyckt L; Karolinska Schizophrenia Project, Busatto GF, Rosa PGP, Serpa MH, Zanetti MV, Hoschl C, Skoch A, Spaniel F, Tomecek D, Hagenaars SP, McIntosh AM, Whalley HC, Lawrie SM, Knöchel C, Oertel-Knöchel V, Stäblein M, Howells FM, Stein DJ, Temmingh HS, Uhlmann A, Lopez-Jaramillo C, Dima D, McMahon A, Faskowitz JI, Gutman BA, Jahanshad N, Thompson PM, Turner JA.

Biol Psychiatry. 2018 Nov 1;84(9):644-654. doi: 10.1016/j.biopsych.2018.04.023. Epub 2018 May 14.

30.

Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations.

Kwong A, Shin VY, Ma ES, Chan CT, Ford JM, Kurian AW, Tai E.

Hong Kong Med J. 2018 Jun;24 Suppl 3(3):4-6. No abstract available.

31.

A positive take on schizophrenia negative symptom scales: Converting scores between the SANS, NSA and SDS.

Preda A, Nguyen DD, Bustillo JR, Belger A, O'Leary DS, McEwen S, Ling S, Faziola L, Mathalon DH, Ford JM, Potkin SG; FBIRN, van Erp TGM.

Schizophr Res. 2018 Nov;201:113-119. doi: 10.1016/j.schres.2018.06.014. Epub 2018 Jun 20.

PMID:
29935887
32.

Polygenic risk score, genome-wide association, and gene set analyses of cognitive domain deficits in schizophrenia.

Nakahara S, Medland S, Turner JA, Calhoun VD, Lim KO, Mueller BA, Bustillo JR, O'Leary DS, Vaidya JG, McEwen S, Voyvodic J, Belger A, Mathalon DH, Ford JM, Guffanti G, Macciardi F, Potkin SG, van Erp TGM.

Schizophr Res. 2018 Nov;201:393-399. doi: 10.1016/j.schres.2018.05.041. Epub 2018 Jun 12.

PMID:
29907492
33.

Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.

Nadauld LD, Ford JM, Pritchard D, Brown T.

Health Aff (Millwood). 2018 May;37(5):751-756. doi: 10.1377/hlthaff.2017.1575. Review.

PMID:
29733728
34.

The function and failure of sensory predictions.

Bansal S, Ford JM, Spering M.

Ann N Y Acad Sci. 2018 Apr 23. doi: 10.1111/nyas.13686. [Epub ahead of print] Review.

PMID:
29683518
35.

Short term evaluation of respiratory effort by premature infants supported with bubble nasal continuous airway pressure using Seattle-PAP and a standard bubble device.

Welty SE, Rusin CG, Stanberry LI, Mandy GT, Gest AL, Ford JM, Backes CH Jr, Richardson CP, Howard CR, Hansen TN, Smith CV.

PLoS One. 2018 Mar 28;13(3):e0193807. doi: 10.1371/journal.pone.0193807. eCollection 2018.

36.

Higher Absolute Lymphocyte Counts Predict Lower Mortality from Early-Stage Triple-Negative Breast Cancer.

Afghahi A, Purington N, Han SS, Desai M, Pierson E, Mathur MB, Seto T, Thompson CA, Rigdon J, Telli ML, Badve SS, Curtis CN, West RB, Horst K, Gomez SL, Ford JM, Sledge GW, Kurian AW.

Clin Cancer Res. 2018 Jun 15;24(12):2851-2858. doi: 10.1158/1078-0432.CCR-17-1323. Epub 2018 Mar 26.

37.

Disrupted network cross talk, hippocampal dysfunction and hallucinations in schizophrenia.

Hare SM, Law AS, Ford JM, Mathalon DH, Ahmadi A, Damaraju E, Bustillo J, Belger A, Lee HJ, Mueller BA, Lim KO, Brown GG, Preda A, van Erp TGM, Potkin SG, Calhoun VD, Turner JA.

Schizophr Res. 2018 Sep;199:226-234. doi: 10.1016/j.schres.2018.03.004. Epub 2018 Mar 21.

PMID:
29571753
38.

Nano-Pulsed Laser Therapy Is Neuroprotective in a Rat Model of Blast-Induced Neurotrauma.

Esenaliev RO, Petrov IY, Petrov Y, Guptarak J, Boone DR, Mocciaro E, Weisz H, Parsley MA, Sell SL, Hellmich H, Ford JM, Pogue C, DeWitt D, Prough DS, Micci MA.

J Neurotrauma. 2018 Jul 1;35(13):1510-1522. doi: 10.1089/neu.2017.5249. Epub 2018 Apr 30.

39.

Precision oncology in advanced cancer patients improves overall survival with lower weekly healthcare costs.

Haslem DS, Chakravarty I, Fulde G, Gilbert H, Tudor BP, Lin K, Ford JM, Nadauld LD.

Oncotarget. 2018 Feb 2;9(15):12316-12322. doi: 10.18632/oncotarget.24384. eCollection 2018 Feb 23.

40.

Rapid detection of BRCA1/2 recurrent mutations in Chinese breast and ovarian cancer patients with multiplex SNaPshot genotyping panels.

Kwong A, Ho JCW, Shin VY, Kurian AW, Tai E, Esserman LJ, Weitzel JN, Lin PH, Field M, Domchek SM, Lo J, Ngan HYS, Ma ESK, Chan TL, Ford JM.

Oncotarget. 2017 Dec 20;9(8):7832-7843. doi: 10.18632/oncotarget.23471. eCollection 2018 Jan 30.

41.

Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms.

Ferri J, Ford JM, Roach BJ, Turner JA, van Erp TG, Voyvodic J, Preda A, Belger A, Bustillo J, O'Leary D, Mueller BA, Lim KO, McEwen SC, Calhoun VD, Diaz M, Glover G, Greve D, Wible CG, Vaidya JG, Potkin SG, Mathalon DH.

Psychol Med. 2018 Nov;48(15):2492-2499. doi: 10.1017/S003329171800003X. Epub 2018 Feb 15.

PMID:
29444726
42.

Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for Psychosis.

Fryer SL, Roach BJ, Ford JM, Donaldson KR, Calhoun VD, Pearlson GD, Kiehl KA, Srihari VH, McGlashan TH, Woods SW, Mathalon DH.

Schizophr Bull. 2019 Jan 1;45(1):158-168. doi: 10.1093/schbul/sbx198.

PMID:
29385625
43.

Patient communication of cancer genetic test results in a diverse population.

Ricker CN, Koff RB, Qu C, Culver J, Sturgeon D, Kingham KE, Lowstuter K, Chun NM, Rowe-Teeter C, Lebensohn A, Levonian P, Partynski K, Lara-Otero K, Hong C, Petrovchich IM, Mills MA, Hartman AR, Allen B, Ladabaum U, McDonnell K, Ford JM, Gruber SB, Kurian AW, Idos GE.

Transl Behav Med. 2018 Jan 29;8(1):85-94. doi: 10.1093/tbm/ibx010.

44.

Can Functional Movement Assessment Predict Football Head Impact Biomechanics?

Ford JM, Campbell KR, Ford CB, Boyd KE, Padua DA, Mihalik JP.

Med Sci Sports Exerc. 2018 Jun;50(6):1233-1240. doi: 10.1249/MSS.0000000000001538.

PMID:
29293120
45.

Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.

Telli ML, Hellyer J, Audeh W, Jensen KC, Bose S, Timms KM, Gutin A, Abkevich V, Peterson RN, Neff C, Hughes E, Sangale Z, Jones J, Hartman AR, Chang PJ, Vinayak S, Wenstrup R, Ford JM.

Breast Cancer Res Treat. 2018 Apr;168(3):625-630. doi: 10.1007/s10549-017-4624-7. Epub 2017 Dec 23.

PMID:
29275435
46.

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.

Doherty MR, Cheon H, Junk DJ, Vinayak S, Varadan V, Telli ML, Ford JM, Stark GR, Jackson MW.

Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):13792-13797. doi: 10.1073/pnas.1713728114. Epub 2017 Dec 11.

47.

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.

Gupta S, Provenzale D, Regenbogen SE, Hampel H, Slavin TP, Hall MJ, Llor X, Chung DC, Ahnen DJ, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Markowitz AJ, Mayer RJ, Ness RM, Samadder NJ, Shike M, Sugandha S, Weiss JM, Dwyer MA, Ogba N.

J Natl Compr Canc Netw. 2017 Dec;15(12):1465-1475. doi: 10.6004/jnccn.2017.0176.

PMID:
29223984
48.

Deficits in Cortical Suppression During Vocalization are Associated With Structural Abnormalities in the Arcuate Fasciculus in Early Illness Schizophrenia and Clinical High Risk for Psychosis.

Whitford TJ, Oestreich LKL, Ford JM, Roach BJ, Loewy RL, Stuart BK, Mathalon DH.

Schizophr Bull. 2018 Oct 17;44(6):1312-1322. doi: 10.1093/schbul/sbx144.

PMID:
29194516
49.

Erratum: Author Correction: The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.

Slavin TP, Maxwell KN, Lilyquist J, Vijai J, Neuhausen SL, Hart SN, Ravichandran V, Thomas T, Maria A, Villano D, Schrader KA, Moore R, Hu C, Wubbenhorst B, Wenz BM, D'Andrea K, Robson ME, Peterlongo P, Bonanni B, Ford JM, Garber JE, Domchek SM, Szabo C, Offit K, Nathanson KL, Weitzel JN, Couch FJ.

NPJ Breast Cancer. 2017 Nov 7;3:44. doi: 10.1038/s41523-017-0046-2. eCollection 2017.

50.

The Difficulty in Finding Relationships Between ERPs and Clinical Symptoms of Schizophrenia.

Ford JM.

Clin EEG Neurosci. 2018 Jan;49(1):6-7. doi: 10.1177/1550059417737416. Epub 2017 Nov 2.

PMID:
29094613

Supplemental Content

Support Center